UK 10:32 Tuesday, 22 September 2026
Breaking news and expert analysis on fast-moving AIM and LSE listed shares
Disclosure: I own shares in one or more of the stocks mentioned. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.
I'm not suggesting anything inappropriate - just making an analogy, as I discuss Zephyr Energy (ZPHR). Then, I touch on Optibiotix (OPTI), and a chat with Steve O'Hara. If you'd like to spend a day with Steve over all day drink and home-produced Welsh food, you can of course do so, HERE. I am pleased to say that almost a third of the seats are already booked out. After that, it is onto Oxford Biodynamics (OBD) and Shield Therapeutics (STX) - will its placing be at 5p, or not at all?. Then, Pennon (PNN), sewage and Feargal Sharkey. Finally, Abingdon Diagnostics (ABDX), where good news has seen the shares rocket. However, that only postpones the next bailout placing (or death) until Adven
Already a member? Sign in
• All premium articles
• Tom Winnifrith’s Bearcast
• Access to all the entire nearly 13 year archive
• ShareProphets Daily Newsletter
Cancel any time
This area of the ShareProphets.com site is for independent financial commentary. These blogs are provided by independent authors via a common carrier platform and do not represent the opinions of ShareProphets.com. ShareProphets.com does not monitor, approve, endorse or exert editorial control over these articles and does not therefore accept responsibility for or make any warranties in connection with or recommend that you or any third party rely on such information. The information available at ShareProphets.com is for your general information and use and is not intended to address your particular requirements. In particular, the information does not constitute any form of advice or recommendation by ShareProphets.com and is not intended to be relied upon by users in making (or refraining from making) any investment decisions.
